CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 831 - 840 of 842
Study Number Lead Group Study Title CIRB Study Status
E2603 ECOG A Double-blind; Randomized; Placebo-Controlled Phase III Trial of Carboplatin; Paclitaxel and Sorafenib Versus Carboplatin; Paclitaxel and Placebo in Patients with Unresectable Locally Advanced or Stage IV Melanoma Adult CIRB - Late Phase Emphasis Available to Open
S1619 SWOG A Feasibility Trial of Neoadjuvant Cisplatin-Pemetrexed with Atezolizumab in Combination and in Maintenance for Resectable Malignant Pleural Mesothelioma Adult CIRB - Late Phase Emphasis Available to Open
9984 ETCTN A Randomized Phase 2 Study of cediranib in Combination with olaparib versus olaparib alone in men with metastatic castration resistant prostate cancer Adult CIRB - Early Phase Emphasis Available to Open
S1900A SWOG A Phase II Study of Rucaparib in Patients with Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-Small Cell Lung Cancer (LungMAP Sub-Study) Adult CIRB - Late Phase Emphasis Available to Open
NRG-CC007CD NRG Increasing the Dose of Survivorship Care Planning in Prostate Cancer Survivors Who Receive Androgen Deprivation Therapy Cancer Prevention and Control CIRB Available to Open
AALL03B1 COG Classification of Acute Lymphoblastic Leukemia Pediatric CIRB Available to Open
S1400 SWOG A Biomarker-Driven Master Protocol for Previously Treated Squamous Cell Lung Cancer (Lung-Map) Adult CIRB - Late Phase Emphasis Available to Open
ABTC-1804 ABTC Determining the Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients with Gliomas Adult CIRB - Late Phase Emphasis Available to Open
A011401 Alliance Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer Adult CIRB - Late Phase Emphasis Available to Open
S1929 SWOG Phase II Randomized Study of Maintenance Atezolizumab Versus Atezolizumab in Combination with Talazoparib in Patients with SLFN11 Positive Extensive Stage Small Cell Lung Cancer (ES-SCLC) Adult CIRB - Late Phase Emphasis Available to Open
Displaying 831 - 840 of 842